Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 211,354 shares at $13.19 ($2.8M) on 2020-12-14, disclosed to the SEC on 2020-12-15.
Open-market sale of $2.8M VNDA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.88 | 35,053 | $451K | 16.4% |
| 2 | $12.88 | 35,053 | $451K | 16.4% |
| 3 | $13.19 | 51,049 | $673K | 24.4% |
| 4 | $13.19 | 51,049 | $673K | 24.4% |
| 5 | $13.00 | 39,150 | $509K | 18.4% |
| Total | $13.05 avg | 211,354 |
| $2.8M |
| 100% |
| Filing → |
| VNDA | BUY | 2025-05-21 | $44K | — | Filing → |
| VNDA | BUY | 2025-05-19 | $84K | — | Filing → |
| VNDA | BUY | 2025-03-06 | $50K | — | Filing → |